C301-3374 Screening compound: 2-[4-(4-tert-butylbenzenesulfonyl)piperazin-1-yl]-3-(3,5-dimethyl-1H-pyrazol-1-yl)quinoxaline

C301-3374 Screening compound: 2-[4-(4-tert-butylbenzenesulfonyl)piperazin-1-yl]-3-(3,5-dimethyl-1H-pyrazol-1-yl)quinoxaline
C301-3374 Screening compound: 2-[4-(4-tert-butylbenzenesulfonyl)piperazin-1-yl]-3-(3,5-dimethyl-1H-pyrazol-1-yl)quinoxaline alternative view

Chemical Structure Depiction of ChemDiv screening compound C301-3374
2-[4-(4-tert-butylbenzenesulfonyl)piperazin-1-yl]-3-(3,5-dimethyl-1H-pyrazol-1-yl)quinoxaline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C301-3374

Molecular Formula

C27H32N6O2S (C27 H32 N6 O2 S)

Compound Name

2-[4-(4-tert-butylbenzenesulfonyl)piperazin-1-yl]-3-(3,5-dimethyl-1H-pyrazol-1-yl)quinoxaline

IUPAC name

2-[4-(4-tert-butylbenzenesulfonyl)piperazin-1-yl]-3-(35-dimethyl-1H-pyrazol-1-yl)quinoxaline

SMILES

CC(C)(C)c(cc1)ccc1S(N(CC1)CCN1c1nc2ccccc2nc1-n1nc(C)cc1C)(=O)=O

InChI

InChI=1S/C27H32N6O2S/c1-19-18-20(2)33(30-19)26-25(28-23-8-6-7-9-24(23)29-26)31-14-16-32(17-15-31)36(34,35)22-12-10-21(11-13-22)27(3,4)5/h6-13,18H,14-17H2,1-5H3

InChI Key

PBKBUHHHLHIHEJ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD07435775

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

504.66

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.685

Distribution Coefficient, logD

5.684

Water Solubility, LogSw

-5.64

Polar Surface Area

65.880

Acid Dissociation Constant (pKa)

24.21

Base Dissociation Constant (pKb)

4.85

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

C301-3374 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C301-3374 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C301-3374?
Check Price and Availability of C301-3374, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C301-3374 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C301-3374
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C301-3374
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C301-3374 available by request